The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
Verve Therapeutics Inc (NASDAQ: VERV) closed the day trading at $5.19 down -5.64% from the previous closing price of $5.50. In other words, the price has decreased by -$5.64 from its previous closing price. On the day, 2.92 million shares were traded. VERV stock price reached its highest trading level at $5.68 during the session, while it also had its lowest trading level at $5.16.
Ratios:
For a better understanding of VERV, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.65 and its Current Ratio is at 12.65. In the meantime, Its Debt-to-Equity ratio is 0.14 whereas as Long-Term Debt/Eq ratio is at 0.12.
On April 08, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $15.
On April 13, 2023, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $29.Canaccord Genuity initiated its Buy rating on April 13, 2023, with a $29 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 02 ’25 when Kathiresan Sekar sold 9,822 shares for $4.15 per share. The transaction valued at 40,761 led to the insider holds 346,686 shares of the business.
Nickerson Joan sold 2,777 shares of VERV for $11,525 on Apr 02 ’25. The Chief Administrative Officer now owns 17,420 shares after completing the transaction at $4.15 per share. On Apr 02 ’25, another insider, Ashe Andrew D., who serves as the insider of the company, sold 2,681 shares for $4.15 each. As a result, the insider received 11,126 and left with 348,828 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VERV now has a Market Capitalization of 462653216 and an Enterprise Value of 6552036. For the stock, the TTM Price-to-Sale (P/S) ratio is 14.31 while its Price-to-Book (P/B) ratio in mrq is 0.93. Its current Enterprise Value per Revenue stands at 0.203 whereas that against EBITDA is -0.03.
Stock Price History:
The Beta on a monthly basis for VERV is 1.81, which has changed by -0.19032758 over the last 52 weeks, in comparison to a change of 0.09765589 over the same period for the S&P500. Over the past 52 weeks, VERV has reached a high of $9.31, while it has fallen to a 52-week low of $2.86. The 50-Day Moving Average of the stock is -3.13%, while the 200-Day Moving Average is calculated to be -11.47%.
Shares Statistics:
Over the past 3-months, VERV traded about 2.73M shares per day on average, while over the past 10 days, VERV traded about 3055140 shares per day. A total of 88.76M shares are outstanding, with a floating share count of 66.38M. Insiders hold about 25.54% of the company’s shares, while institutions hold 70.63% stake in the company. Shares short for VERV as of 1744675200 were 16564181 with a Short Ratio of 6.06, compared to 1741910400 on 15274886. Therefore, it implies a Short% of Shares Outstanding of 16564181 and a Short% of Float of 22.009999999999998.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
